Loading...
XKRX
000640
Market cap567mUSD
Jul 11, Last price  
121,500.00KRW
1D
-0.08%
1Q
24.11%
Jan 2017
-22.36%
Name

Dong-A Socio Holdings Co Ltd

Chart & Performance

D1W1MN
P/E
13.48
P/S
0.59
EPS
9,015.64
Div Yield, %
0.58%
Shrs. gr., 5y
0.68%
Rev. gr., 5y
11.61%
Revenues
1.33t
+17.78%
686,809,156,000763,589,003,000866,234,795,000947,638,085,0001,055,699,080,2501,105,996,371,970570,870,106,640630,625,193,750704,734,520,020726,165,504,520690,264,581,710707,170,723,240769,685,605,090783,315,662,470881,944,084,0301,014,860,897,9501,132,002,860,4001,333,229,636,660
Net income
58.02b
+0.06%
34,763,877,00043,375,193,00063,263,267,00071,482,696,00069,219,623,00085,877,512,60015,568,205,9101,715,985,59047,883,250,600149,051,293,02032,543,386,670-163,977,361,48019,764,497,050162,345,444,36060,270,881,3107,835,195,64057,989,523,14058,022,061,470
CFO
82.99b
-47.70%
44,496,394,00063,530,432,00096,724,584,000144,600,127,000121,502,517,02055,724,205,08035,782,979,340-7,915,516,97080,936,807,40030,476,158,12084,456,509,83058,321,851,92096,786,624,59084,572,091,360131,087,231,09075,874,278,310158,697,909,56082,994,953,700
Dividend
Jun 27, 2024700 KRW/sh
Earnings
Jul 23, 2025

Profile

Dong-A Socio Holdings Co., Ltd. engages in the pharmaceutical business in South Korea and internationally. It offers Bacchus, Benachio, and Tempo; infection management products; imaging equipment, such as FX-V1 and CLS-S7 for surgery and diagnosis; and MEDIFLIX, a medical knowledge-sharing platform. The company provides business management services; CMO services, including pre-clinical study, clinical trial, and commercial production of antibodies and recombinant proteins; maintenance, repair, and operation; quarantine; and military logistics services; and packaging and parcel delivery services. In addition, it offers mineral water under the Gayasan Cheonnyeonsu brand; POCARI SWEAT; Narangd cider; Oronamin C; Oran-C bio-PET; and STP2104, an mRNA based COVID-19 vaccine, which is in phase I clinical trial. Further, the company engages in the construction of industrial facilities, such as bio, pharmaceutical, food, logistics warehouses, education/research facilities, work/sales facilities, and public facilities; provides design, maintenance, and asset development services. Additionally, it provides IT systems development and maintenance. The company was founded in 1932 and is headquartered in Seoul, South Korea.
URL
http://www.donga.co.kr/
IPO date
Feb 10, 1970
Employees
Domiciled in
KR
Incorporated in
KR

Valuation

Title
KRW in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
1,333,229,637
17.78%
1,132,002,860
11.54%
1,014,860,898
15.07%
Cost of revenue
1,124,349,990
935,534,981
861,721,111
Unusual Expense (Income)
NOPBT
208,879,647
196,467,880
153,139,787
NOPBT Margin
15.67%
17.36%
15.09%
Operating Taxes
18,764,404
9,870,691
9,773,384
Tax Rate
8.98%
5.02%
6.38%
NOPAT
190,115,243
186,597,188
143,366,402
Net income
58,022,061
0.06%
57,989,523
640.12%
7,835,196
-87.00%
Dividends
(11,876,374)
(12,501,446)
(9,375,974)
Dividend yield
1.70%
1.98%
1.48%
Proceeds from repurchase of equity
(83,111,315)
BB yield
13.10%
Debt
Debt current
510,945,188
420,088,777
409,783,530
Long-term debt
342,685,867
376,059,483
194,960,196
Deferred revenue
14,627,089
13,527,827
8,797,332
Other long-term liabilities
13,943,867
12,581,337
3,240,052
Net debt
71,706,243
21,058,775
(134,799,839)
Cash flow
Cash from operating activities
82,994,954
158,697,910
75,874,278
CAPEX
(49,574,001)
(150,114,314)
(78,600,552)
Cash from investing activities
(45,178,531)
(161,359,976)
(42,465,377)
Cash from financing activities
(40,449,138)
27,393,049
(38,001,749)
FCF
105,318,785
43,789,964
97,617,382
Balance
Cash
127,344,866
154,691,260
103,386,538
Long term investments
654,579,946
620,398,224
636,157,027
Excess cash
715,263,331
718,489,341
688,800,520
Stockholders' equity
819,494,251
787,586,066
759,936,395
Invested Capital
1,117,210,304
1,026,810,794
859,272,112
ROIC
17.73%
19.79%
17.00%
ROCE
11.36%
11.24%
9.81%
EV
Common stock shares outstanding
6,349
6,251
6,251
Price
109,800.00
8.71%
101,000.00
-0.49%
101,500.00
-11.74%
Market cap
697,110,647
10.42%
631,323,023
-0.49%
634,448,384
-10.73%
EV
783,143,219
667,219,917
642,957,155
EBITDA
298,113,553
270,638,789
223,873,164
EV/EBITDA
2.63
2.47
2.87
Interest
29,293,843
22,745,717
14,853,870
Interest/NOPBT
14.02%
11.58%
9.70%